BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tiwari PK. Epigenetic Biomarkers in Gallbladder Cancer. Trends Cancer 2020;6:540-3. [PMID: 32291238 DOI: 10.1016/j.trecan.2020.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Gondkar K, Parvathi JR, Kumar P. Integrative Omics: The Roadmap for Gallbladder Biomarkers Identification. Gallbladder Cancer 2023. [DOI: 10.1007/978-981-19-6442-8_17] [Reference Citation Analysis]
2 Liang R, Zhang X, Zhao J, Zhu R, Wang W, Lu Q, Sun Y. Ubiquitin-specific protease 3 facilitates cell proliferation by deubiquitinating pyruvate kinase L/R in gallbladder cancer. Lab Invest 2022. [DOI: 10.1038/s41374-022-00836-1] [Reference Citation Analysis]
3 Qiu Z, Ji J, Xu Y, Zhu Y, Gao C, Wang G, Li C, Zhang Y, Zhao J, Wang C, Wen X, Zhang Z, Li B, Zhang Z, Cai S, Li B, Jiang X. Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes. BMC Med 2022;20:64. [PMID: 35130881 DOI: 10.1186/s12916-021-02197-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li Z, Jiang Q, Chen X, Xiao Y, Xiao J. Primary Hepatoid Adenocarcinoma of Gallbladder With MB21D2/GALNT12/ARID2 Mutations: A Case Report. Front Endocrinol (Lausanne) 2021;12:791153. [PMID: 35046897 DOI: 10.3389/fendo.2021.791153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yang C, Chen J, Yu Z, Luo J, Li X, Zhou B, Jiang N. Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma. Front Oncol 2021;11:621806. [PMID: 33718182 DOI: 10.3389/fonc.2021.621806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Zhang X, Kong Z, Xu X, Yun X, Chao J, Ding D, Li T, Gao Y, Guan N, Zhu C, Qin X. ARRB1 Drives Gallbladder Cancer Progression by Facilitating TAK1/MAPK Signaling Activation. J Cancer 2021;12:1926-35. [PMID: 33753990 DOI: 10.7150/jca.53325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis 2020;11:871. [PMID: 33067424 DOI: 10.1038/s41419-020-03080-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]